Current NHS eligibility criteria for semaglutide 2.4 mg (Wegovy) for weight management, according to NICE TA875, include: Body Mass Index (BMI) 35 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea) For people from certain high-risk ethnic groups (such as South Asian, Chinese, Black African, or African-Caribbean), lower BMI thresholds apply (typically reduced by 2.5 kg/m) Treatment must be prescribed within specialist weight management services only Treatment is limited to a maximum duration of 2 years Must be used as an adjunct to a reduced-calorie diet and increased physical activity Liraglutide 3 mg (Saxenda) availability varies significantly across NHS regions and is not routinely commissioned in many areas
When should you speak to a Clinician
Known for turning complex data into clear, practical insights, Michelle focuses on helping professionals confidently interpret data, think critically, and apply evidence in everyday decision-making
These three mRNAs collectively encode the G6PD isoform a (545 amino acids) and isoform b (515 amino acids) enzymes
Regular exercise accelerates weight loss, improves cardiovascular health, and boosts mood
&srotate=0)
